A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...
For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...
Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
The 67 th American Society for Radiation Oncology (ASTRO) annual meeting held in San Francisco., between September 28 and September 30 was host to the Session16 - GU 4: Quality of Life Outcomes after ...
Stereotactic body radiation therapy (SBRT), defined as the delivery of >5Gy per fraction, has emerged as a well-established standard of care option for the definitive management of localized prostate ...
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma Clinical trials frequently include multiple ...
Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved ...
In a clinical practice guideline published in Practical Radiation Oncology, recommendations are presented for the use of postmastectomy radiation therapy (PMRT).
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new phase III randomized trial.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback